Evidence map›Paper›PMID 41346354›Full record

ArticleJournal of pharmaceutical policy and practice2025

Building the U.S.-ASEAN Consortium for Pharmacy Education based on the U.S.-Thai Consortium experience: a qualitative study.

Phayom Sookaneknun Olson, Surakit Nathisuwan, Michael D Katz, Pornchanok Srimongkon, Paul W Jungnickel, Chanuttha Ploylearmsang, Areerut Leelathanalerk, Melody Ryan, Thitima Doungngern, Gary M Oderda and 6 more

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Phayom Sookaneknun OlsonInternational Primary Care Practice Research Unit (iPCPRU), Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, Thailand.ORCID https://orcid.org/0000-0002-3618-3115
Surakit NathisuwanDepartment of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
Michael D KatzDepartment of Pharmacy Practice & Science, R.Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Pornchanok SrimongkonClinical Pharmacy Division, Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, Thailand.ORCID https://orcid.org/0000-0002-2062-2005
Paul W JungnickelHarrison College of Pharmacy, Auburn University, Auburn, AL, USA.
Chanuttha PloylearmsangInternational Primary Care Practice Research Unit (iPCPRU), Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, Thailand.ORCID https://orcid.org/0000-0002-8158-0312
Areerut LeelathanalerkInternational Primary Care Practice Research Unit (iPCPRU), Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, Thailand.ORCID https://orcid.org/0009-0008-6372-394X
Melody RyanDepartment of Pharmacy Practice & Science, College of Pharmacy, University of Kentucky, Lexington, KY, USA.ORCID https://orcid.org/0000-0002-2098-3775
Thitima DoungngernClinical Pharmacy Division, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand.ORCID https://orcid.org/0000-0002-4281-6476
Gary M OderdaCollege of Pharmacy, University of Utah, Salt Lake City, UT, USA.
Alan H LauRetzky College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA.ORCID https://orcid.org/0000-0002-9245-6659
Sutthiporn PattharachayakulClinical Pharmacy Division, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand.ORCID https://orcid.org/0000-0002-2879-2105
Pansakon WattanachaiClinical Pharmacy Division, Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, Thailand.
Mantiwee NimworapanDepartment of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.ORCID https://orcid.org/0000-0002-7691-0348
Theerapong SeesinInternational Primary Care Practice Research Unit (iPCPRU), Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, Thailand.ORCID https://orcid.org/0000-0002-6579-7458
Pemmarin PotisarachInternational Primary Care Practice Research Unit (iPCPRU), Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, Thailand.ORCID https://orcid.org/0000-0003-4192-8414

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The U.S.-Thai Consortium for Pharmacy Education is a long-standing collaboration between the U.S. and Thailand that primarily focuses on faculty development. The success of this partnership has contributed to the improvement of pharmacy education and the advancement of pharmacy practice in Thailand. It may also serve as a model for collaborative efforts in pharmacy education and practice across Association of Southeast Asian Nations (ASEAN) countries. This study was designed to explore the views and perceptions on goals, directions, and trends for the new U.S.- ASEAN Consortium for Pharmacy Education. Methods: A qualitative study was used. A focus group with semi-structured questions was conducted with 12 representative faculty members from nine ASEAN countries and the U.S. Verbatim transcriptions were used to perform thematic analysis with investigator triangulation. Results: Four key themes emerged: perceptions, challenges, expectations, and directions. Participants perceived the U.S.-ASEAN Consortium as a strategic networking platform for expanding international collaborations. Challenges were identified at both the institutional and national levels, with curriculum differences, financial constraints, and administrative issues affecting institutions, while cultural and language differences pose further obstacles. At the national level, top-down administrative structures were identified as restrictions. The main expressed benefit of joining the Consortium was enhancement of student experiences, including student exchange programmes. Gaining insights into organisational administration was also perceived as one of the benefits. Participants recognised that a successful collaboration required identifying common interests, setting goals, and proposing strategies, including developing a master plan, harmonising programmes, and establishing a uniform competency framework. Regular meetings and resource-sharing were identified as also essential to maintaining the engagement of Consortium members. Conclusion: The U.S.-ASEAN Consortium was perceived as a platform to increase opportunities to collaboratively connect with other pharmacy schools internationally. The establishment of common interests and strategies was recommended to keep the collaboration moving forward.

Indexed as

ASEANPharmacy educationPharmacy practiceU.S.-ASEAN ConsortiumU.S.-Thai Consortium

Identifiers

PMID41346354
PMCPMC12673976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.